N2Jenomics Lab Pvt. Ltd. offers comprehensive and highly flexible genotyping services tailored to projects of all sizes—from small-scale studies to large population-based research—as well as standard and fully customized workflows. Our services support human samples and a wide range of plant, animal, and microbial species.
Leveraging an advanced portfolio of high-density genotyping arrays, premium-quality reagents, automated platforms, and robust bioinformatics pipelines, we deliver accurate and reliable detection of single nucleotide polymorphisms (SNPs), copy number variations (CNVs), insertions/deletions (Indels), and other genetic variants.
Designed to meet the diverse needs of research, agricultural, clinical, and pharmaceutical applications, our scalable genotyping solutions ensure exceptional data quality, rapid turnaround times, and cost-effective performance. Backed by experienced scientists, cutting-edge technologies, and stringent quality standards, N2Jenomics Lab Pvt. Ltd. is a trusted partner for delivering high-confidence genotyping results that accelerate genomic discoveries.
Genotyping is a molecular genetic technique used to identify the specific genetic variants, or alleles, present at particular locations (loci) within an organism's genome. By analyzing DNA sequences, researchers can determine an individual's unique genetic makeup and study how genetic differences contribute to biological traits, disease susceptibility, and phenotypic diversity.
The process involves comparing a DNA sample with a reference genome or another sample to detect genetic variations, including single nucleotide polymorphisms (SNPs), copy number variations (CNVs), insertions/deletions (Indels), and other sequence alterations. These insights help establish relationships between genotype and phenotype, enabling researchers to understand the genetic basis of inherited traits, diseases, and population diversity.
Genotyping has become an indispensable tool across genomics research, precision medicine, agricultural breeding, evolutionary biology, and population genetics, providing valuable information for biomarker discovery, disease association studies, genetic mapping, and personalized healthcare.
Single Nucleotide Polymorphisms (SNPs) are the most abundant form of genetic variation, representing single base-pair changes within the DNA sequence. Typically occurring once every 1,000 base pairs, SNPs are distributed throughout the genome, including coding, non-coding, regulatory, and intronic regions. These genetic variations can influence gene expression, transcription factor binding, RNA splicing, protein structure, and numerous other biological processes, ultimately contributing to individual diversity, disease susceptibility, and evolutionary adaptation.
As one of the two major sources of genetic variation—alongside Copy Number Variations (CNVs)—SNPs serve as powerful molecular markers for investigating complex traits and diseases. SNP genotyping has become an essential tool in genomics research, enabling applications such as disease association studies, precision medicine, pharmacogenomics, population genetics, agricultural breeding, and personalized healthcare.
Depending on the research objectives, SNP genotyping is generally categorized into two approaches:
Selecting the appropriate genotyping technology is critical for generating reliable, high-quality data while meeting the specific goals of each project. N2Jenomics Lab Pvt. Ltd. provides flexible, high-throughput SNP genotyping solutions that support projects ranging from targeted marker validation to comprehensive genome-wide analysis. Our advanced genotyping platforms enable the analysis of thousands to millions of genetic markers with exceptional accuracy, reproducibility, and scalability.
By integrating state-of-the-art technologies, optimized laboratory workflows, and comprehensive bioinformatics analysis, we deliver high-density genome-wide coverage and the latest scientifically validated marker content. Whether your research focuses on human health, agriculture, animal genetics, or evolutionary biology, our SNP genotyping services provide robust, reliable, and actionable genomic insights to accelerate scientific discovery.
Genotyping encompasses a range of molecular techniques used to identify and characterize genetic variations within an individual's genome. The choice of method depends on factors such as the number of genetic markers to be analyzed, sample throughput, required resolution, and the objectives of the study. Below are the key methodologies commonly employed in modern genotyping workflows.
The first step in any genotyping workflow is the extraction of high-quality genomic DNA. DNA is isolated from biological samples such as whole blood, saliva, tissue, buccal swabs, cultured cells, or formalin-fixed paraffin-embedded (FFPE) tissues. During extraction, cellular components, proteins, and contaminants are removed to obtain purified DNA suitable for downstream molecular analysis. Depending on the sample type and application, extraction can be performed using conventional organic methods or automated column- and magnetic bead-based purification systems.
Hybridization is a fundamental principle underlying many genotyping technologies, including microarrays, PCR-based assays, and next-generation sequencing (NGS). It involves the specific binding of complementary single-stranded DNA molecules through base-pair matching. This highly specific interaction enables accurate detection and identification of genetic variants across the genome.
Polymerase Chain Reaction (PCR) is one of the most widely used methods for genotyping due to its speed, sensitivity, and accuracy. PCR selectively amplifies target DNA regions, allowing the detection of specific genetic variants. Common PCR-based genotyping approaches include:
These techniques are extensively applied in clinical research, disease association studies, and molecular diagnostics.
The MassARRAY® iPLEX platform combines multiplex PCR with single-base extension chemistry and MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization–Time of Flight) mass spectrometry for precise SNP genotyping. This technology enables simultaneous analysis of multiple genetic markers with high accuracy, making it well suited for medium- to high-throughput validation studies, pharmacogenomics, and targeted genetic screening.
Pyrosequencing is a sequencing-by-synthesis technology designed for accurate analysis of short DNA fragments. During DNA synthesis, the incorporation of each nucleotide generates a measurable light signal, allowing real-time determination of DNA sequences. This method is particularly useful for SNP genotyping, mutation detection, methylation analysis, and validation of sequence variants.
Microarray technology enables high-throughput analysis of hundreds of thousands to millions of genetic variants in a single experiment. Platforms such as Illumina Infinium® and Affymetrix GeneChip® use allele-specific probes immobilized on a solid surface to detect SNPs and other genomic variations through DNA hybridization. Following hybridization, fluorescent signal intensities are measured to accurately determine genotypes.
Microarray-based genotyping is widely used for:
Next-Generation Sequencing (NGS) has revolutionized genotyping by enabling comprehensive detection of genetic variants across targeted regions, exomes, or entire genomes. Unlike traditional genotyping methods that focus on predefined markers, NGS can identify both known and novel variants, including SNPs, insertions/deletions (Indels), structural variants, and copy number changes.
NGS-based genotyping offers exceptional sensitivity, scalability, and genome-wide coverage, making it the preferred approach for precision medicine, rare disease research, cancer genomics, and large-scale population studies.
Our genotyping service portfolio includes:
High-density genome-wide SNP profiling for Genome-Wide Association Studies (GWAS), population genetics, genomic selection, trait mapping, and genetic diversity analysis.
Accurate validation and characterization of candidate SNPs identified through genome-wide studies, providing high call rates and robust performance for medium- and large-scale sample cohorts.
Comprehensive detection and analysis of genomic copy number gains and losses to support disease research, cancer genomics, and structural variation studies.
High-resolution fragment analysis for applications such as microsatellite (SSR) genotyping, STR analysis, mutation detection, indel analysis, and quality assessment using capillary electrophoresis.
| Service | Sample Type | Recommended Quantity | Minimum Quantity | Minimum Concentration |
| GBS/ddRAD | Genomic DNA | ≥ 300 ng | 100 ng | 10 ng/µL |
| 2b-RAD | Genomic DNA | ≥ 200 ng | 50 ng | 5 ng/µL |
| SNP Microarray | Genomic DNA | ≥ 300 ng | 100 ng | 8 ng/µL |
| SSR Genotyping | Genomic DNA | ≥ 500 ng | 200 ng | 10 ng/µL |
The fundamental input data can comprise diverse types of microarray chip data and next-generation sequencing data such as whole genome sequencing or whole exome sequencing data. Ordinarily, genotyping results from microarray chip data are furnished by the chip manufacturer. The subsequent pipeline delineates the systematic approach to analyzing genotyping by utilizing whole genome sequencing data.

At N2Jenomics Lab Pvt. Ltd., we are committed to delivering accurate, reliable, and high-quality genotyping solutions that support diverse research and clinical applications. Our comprehensive services combine advanced technologies, rigorous quality standards, and scientific expertise to provide dependable results tailored to your research objectives.
We provide flexible genotyping solutions capable of handling projects ranging from a few samples to large-scale population studies. Our diverse portfolio of SNP genotyping platforms enables efficient analysis of hundreds to millions of genetic markers across varying project sizes.
Every project undergoes comprehensive quality control throughout sample processing, genotyping, and data analysis. Our rigorous QC procedures ensure exceptional data accuracy, reproducibility, and confidence in every result.
Our scientists assist in selecting the most informative SNP markers and the most appropriate genotyping platform based on your research objectives, sample volume, species, and study design.
We offer both validation of known genetic variants and discovery of novel SNPs using advanced molecular technologies, providing reliable genotyping results for a broad range of research applications.
Results are delivered in user-friendly formats, including Microsoft Excel and standard genotype files. Depending on the project, we also provide:
Results Display
Our advanced bioinformatics pipelines transform complex genotyping data into clear, accurate, and biologically meaningful results. By integrating sophisticated analytical tools, we enable comprehensive analysis of Single Nucleotide Polymorphisms (SNPs) and Copy Number Variations (CNVs) across datasets containing thousands to millions of genetic markers.
Our analysis workflows facilitate: